Back
Rocket Pharmaceuticals Vs. Arvinas Industry Stock Comparison
Sell
38
RCKT
Rocket Pharmaceuticals
Last Price:
22.71
Seasonality Move:
1.71%
Sell
48
ARVN
Arvinas
Last Price:
34.74
Seasonality Move:
-6.12%
Sell
38
Rocket Pharmaceuticals (RCKT)
is a Sell
Is Rocket Pharmaceuticals a Buy, Sell or Hold?
- The current Rocket Pharmaceuticals [RCKT] share price is $23.44. The Score for RCKT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- RCKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Arvinas (ARVN)
is a Sell
Is Arvinas a Buy, Sell or Hold?
- The current Arvinas [ARVN] share price is $34.29. The Score for ARVN is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- ARVN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RCKT Stock Price Chart
What is Rocket Pharmaceuticals's stock price today?
-
The Rocket Pharmaceuticals share price today is $23.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing selling pressure, which indicates risk of future bearish movement.
RCKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.02 | Sell |
| Relative Strength Index (14 RSI): | 34.27 | Sell |
| Chaikin Money Flow: | -225984 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.45 - 27.13) | Sell |
| Bollinger Bands (100): | (25.31 - 29.59) | Sell |
ARVN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.57 | Sell |
| Relative Strength Index (14 RSI): | 28.87 | Sell |
| Chaikin Money Flow: | 591007 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.96 - 42.74) | Sell |
| Bollinger Bands (100): | (32.97 - 46.87) | Sell |
RCKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.33 | Sell |
| 20-day SMA: | 25.47 | Sell |
| 50-day SMA: | 27.36 | Sell |
| 200-day SMA: | 22.98 | Buy |
| 8-day EMA: | 24.23 | Sell |
| 20-day EMA: | 25.24 | Sell |
| 50-day EMA: | 26.42 | Sell |
| 200-day EMA: | 24.27 | Sell |
ARVN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.53 | Sell |
| 20-day SMA: | 38.24 | Sell |
| 50-day SMA: | 43.62 | Sell |
| 200-day SMA: | 30.87 | Buy |
| 8-day EMA: | 35.33 | Sell |
| 20-day EMA: | 37.92 | Sell |
| 50-day EMA: | 40.22 | Sell |
| 200-day EMA: | 35.14 | Sell |
Rocket Pharmaceuticals Earnings Growth & RCKT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.26 per share, an increase this year of $0.38 per share, and an increase next year of $0.83 per share.
Arvinas Earnings Growth & ARVN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.43 per share, a decrease this year of $0.17 per share, and a decrease next year of $0.30 per share.
Rocket Pharmaceuticals Technical Analysis
| Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arvinas Technical Analysis
| Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||